Physician profile
Robin Weir
NPI 1386749380
$2,219.00
in general payments reported to CMS, 2019-2025
18 companies · $582 in 2025
The $582 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $206 · 2022: $388 · 2023: $506 · 2024: $537 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,625.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $849.42 | 2021-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $282.78 | 2024-2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $187.63 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $174.58 | 2021-2024 | Verquvo, Gardasil 9, Vaqta |
| Astrazeneca Pharmaceuticals LP | $142.43 | 2024 | Airsupra |
| Kyowa Kirin, INC. | $130.11 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $116.96 | 2024 | Dupixent |
| Collegium Pharmaceutical, INC. | $68.25 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $45.52 | 2022-2023 | |
| Glaxosmithkline, LLC. | $42.20 | 2021-2022 | |
| Pfizer INC. | $32.45 | 2021 | |
| Ironshore Pharmaceuticals INC. | $27.94 | 2023-2024 | Jornay Pm |
| Ultragenyx Pharmaceutical INC. | $25.23 | 2023 | |
| Scpharmaceuticals INC. | $24.47 | 2025 | |
| Verrica Pharmaceuticals INC. | $19.18 | 2025 | Ycanth |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.89 | 2025 | |
| Sobi, INC | $16.80 | 2021 | |
| Tris Pharma INC | $14.16 | 2023 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Weir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.